Lithiumeter: Version 2.0

Bipolar Disorders

Volumn 18, Issue 8, 2016, Pages 631-641

  Malhi, Gin S ^a,b,c   Gershon, Samuel ^d,e   Outhred, Tim ^a,b,c  

^a St George Hospital and Community Health Service   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

bipolar depression; bipolar disorder; clinical practice; lithium; mania

Indexed keywords

LITHIUM; TRANQUILIZER;

ANALYTICAL EQUIPMENT; ARTICLE; BIPOLAR DISORDER; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL RESEARCH; COGNITIVE DEFECT; DIARRHEA; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DYSGEUSIA; FATIGUE; HEADACHE; HUMAN; LITHIUM BLOOD LEVEL; LITHIUMETER; MAINTENANCE THERAPY; MONOTHERAPY; NAUSEA; POLYDIPSIA; POLYURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SIDE EFFECT; THIRST; TREATMENT INDICATION; TREATMENT PLANNING; TREMOR; VOMITING; WEIGHT GAIN; DIAGNOSTIC EQUIPMENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

ANTIMANIC AGENTS; BIPOLAR DISORDER; DIAGNOSTIC EQUIPMENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; LITHIUM;

EID: 85008433310     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12455     Document Type: Article

References (41)

1. Bauer M, Gitlin M. The Essential Guide to Lithium Treatment. Cham, Switzerland: Springer; 2016. 1 p.
2. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. The Lancet. 2013;381:1672–1682.
3. Malhi GS, Bassett D, Boyce P et al. Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49:1087–1206.
4. American Psychiatric Association (APA). Practice guideline for the treatment of patients with bipolar disorder revision. Am J Psychiatry. 2002;159(suppl 4):1–50.
5. Goodwin GM, Haddad PM, Ferrier IN et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British association for psychopharmacology. J Psychopharmacol. 2016;30:495–553.
6. Yatham LN, Kennedy SH, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013. Bipolar Disord. 2013;15:1–44.
7. Bauer M. Neue evidenz- und konsensbasierte S3-Leitlinie zur Diagnostik und Therapie bipolarer Störungen. Nervenarzt. 2012;83:564–567.
8. NICE. Bipolar disorder: The assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. NICE clinical guideline 185. London: National Institute of Health and Care Excellence; 2015.
9. Grunze H, Vieta E, Goodwin GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14:154–219.
10. Geddes JR, Burgess S, Hawton K et al. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161:217–222.
11. Young AH, McElroy SL, Bauer M et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry. 2010;71:150–162.
12. Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry 2014;75:254–62–quiz263.
13. Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet. 2010;375:385–395.
14. Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry. 2002;159:1005–1010.
15. Hayes J, Prah P, Nazareth I et al. Prescribing trends in bipolar disorder: Cohort study in the United Kingdom THIN primary care database 1995-2009. PLoS ONE. 2011;6:e28725.
16. Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 2016;18:174–182.
17. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: Polytherapy and adherence. Psychiatr Serv. 2008;59:1175–1183.
18. Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DPJ. Adverse Renal, endocrine, hepatic, and metabolic Events during maintenance mood stabilizer treatment for bipolar disorder: A population-based cohort study. PLoS Med. 2016;13:e1002058.
19. Malhi GS, Gessler D, Outhred T, Naylor A. How to Treat: Why, when and how to prescribe lithium. Australian Doctor. 2016;3:21–28.
20. Malhi GS, Tanious M, Gershon S. The lithiumeter: A measured approach. Bipolar Disord. 2011;13:219–226.
21. Gershon S, Yuwiler A. Lithium ion: A specific psychopharmacological approach to the treatment of mania. J Neuropsychiatr. 1960;1:229–241.
22. Grof P, Müller-Oerlinghausen B. A critical appraisal of lithium's efficacy and effectiveness: The last 60 years. Bipolar Disord. 2009;11:10–19.
23. Malhi GS, Porter RJ. Are ‘buy-polar’ forces and “try-polar” thinking expanding bipolarity? Aust N Z J Psychiatry. 2014;48:697–700.
24. Malhi GS, Berk M. Diagnosing bipolar disorder: Defining thresholds and setting boundaries. Aust N Z J Psychiatry 2014;29:48.
25. Gershon S, Chengappa KR, Malhi GS. Lithium specificity in bipolar illness: A classic agent for the classic disorder. Bipolar Disord. 2009;11(s2):34–44.
26. Grof P, Duffy A, Cavazzoni P et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002;63:942–947.
27. Kessing LV, Vradi E, Andersen PK. Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry 2014;1:205.
28. Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Furukawa TA. Mood stabilizers and antipsychotics for acute mania: A systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. CNS Drugs. 2014;28:989–1003.
29. Pacchiarotti I, Bond DJ, Baldessarini RJ et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170:1249–1262.
30. Chen C, Veronese L, Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacol. 2000;50:193–195.
31. Severus WE, Kleindienst N, Seemuller F, Frangou S, Moller HJ, Greil W. What is the optimal serum lithium level in the long-term treatment of bipolar disorder – a review? Bipolar Disord. 2008;10:231–237.
32. Suppes T, Dennehy EB, Hirschfeld RMA et al. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66:870–886.
33. Grof P. Excellent lithium responders: People whose lives have been changed by lithium prophylaxis. Lithium. 1999;50:36–51.
34. Ng F, Mammen OK, Wilting I et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11:559–595.
35. Rybakowski J, Suwalska A. Gastrointestinal, metabolic and body-weight changes during treatment with lithium. In: Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry, Boca Raton, FL: CRC Press; 2013; 283–294.
36. Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: Side effects and compliance. J Clin Psychiatry. 1989;50:127–131.
37. Malhi GS, McAulay C, Gershon S et al. The Lithium Battery: Assessing the neurocognitive profile of lithium in bipolar disorder. Bipolar Disord. 2016;18:102–115.
38. Haussmann R, Bauer M, Bonin S, Grof P, Lewitzka U. Treatment of lithium intoxication: Facing the need for evidence. Int J Bipolar Disord. 2015;3:23.
39. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord. 2004;6:504–518.
40. Berk L, Jorm AF, Kelly CM, Dodd S, Berk M. Development of guidelines for caregivers of people with bipolar disorder: A Delphi expert consensus study. Bipolar Disord. 2011;13:556–570.
41. Murray G, Suto M, Hole R, Hale S, Amari E, Michalak EE. Self-management strategies used by “high functioning” individuals with bipolar disorder: From research to clinical practice. Clin Psychol Psychother. 2010;18:95–109.